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BACKGROUND 
Systemic amyloidoses constitute a complex and heterogeneous group of serious diseases that result 
from protein misfolding and whose common feature is the deposition of pathological protein substances 
(amyloid) in the extracellular space of tissues. Diagnostics of amyloidoses is based on histopathological 
examination of tissue samples and direct demonstration of the presence of amyloid deposits. The overall 
purpose of this diploma thesis was to create, apply and subsequently evaluate a screening program 
focused on systemic amyloidoses. 
METHODS 
In the first part of the experimental study, available staining techniques used for the detection of 
amyloid deposits in the tissue were compared. The second part of the experimental study consisted of 
performing screening examinations on endoscopic biopsy samples of the gastrointestinal tract. 
RESULTS 
Based on the results of comparison, a method employing the Sirius red F3B dye was chosen as 
a suitable screening technique. Within the screening program, a total of 4285 samples from 2572 patients 
were histopathologically examined. In a total of ten samples from five patients, amyloid deposits were 
found, and typing of amyloidosis was performed in four patients. 
CONCLUSIONS 
The aims set at the beginning of this thesis have been met. An up-to-date summary of basic 
information on systemic amyloidoses has been assembled from available literature. Among 
histopathological techniques has been experimentally selected the one that is most suitable for screening 
use, followed by the examination of a total of 4285 samples from 2572 patients. In addition, the results 
have been clinically relevant to the screened patients, since they enabled an appropriate therapy to be 
initiated. 
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